You have 9 free searches left this month | for more free features.

linagliptin

Showing 1 - 25 of 81

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Kidney Transplant; Complications, Diabetes Trial (Empagliflozin 25 MG, Linagliptin)

Not yet recruiting
  • Kidney Transplant; Complications
  • Diabetes Mellitus
  • Empagliflozin 25 MG
  • Linagliptin
  • (no location specified)
Oct 18, 2023

Type 2 Diabetes Trial in Buffalo (Linagliptin, Placebo)

Completed
  • Type 2 Diabetes
  • Linagliptin
  • Placebo
  • Buffalo, New York
    ECMC Ambulatory Center, 3rd Floor
Feb 2, 2022

Type 2 Diabetes, Mild Cognitive Impairment Trial in Nanjing (Liraglutide, Empagliflozin, Linagliptin)

Recruiting
  • Type 2 Diabetes Mellitus
  • Mild Cognitive Impairment
  • Nanjing, Jiangsu, China
  • +1 more
Mar 28, 2022

Type 2 Diabetes Trial in Hortolândia (LID104, Dapagliflozin, Linagliptin)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Hortolândia, SP, Brazil
    Investigational site
May 23, 2023

Cognitive Protective Effect of Newer Antidiabetic Drugs

Recruiting
  • Type 2 Diabetes
  • Alexandria, Egypt
    Alexandria University
Jul 24, 2022

Schizophrenia Trial in Reno (Linagliptin)

Completed
  • Schizophrenia
  • Linagliptin
  • Reno, Nevada
    University of Nevada School of Medicine
Nov 5, 2020

Coronavirus Infection, Type 2 Diabetes Trial in Miami (Linagliptin, Insulin regimen)

Withdrawn
  • Coronavirus Infection
  • Type 2 Diabetes
  • Linagliptin
  • Insulin regimen
  • Miami, Florida
    University of Miami
Jun 7, 2021

Diabetes, Type 2, Left Ventricular Systolic Dysfunction Trial in Italy (Linagliptin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Left Ventricular Systolic Dysfunction
  • Linagliptin
  • Placebo
  • Bergamo, BG, Italy
  • +18 more
May 21, 2021

Diabetes, Type 2 Trial in Worldwide (Linagliptin, Empagliflozin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Linagliptin
  • +2 more
  • Phoenix, Arizona
  • +82 more
Aug 23, 2022

Type 2 Diabetes, Coronary Artery Disease Trial in Graz (Linagliptin, Placebo)

Completed
  • Type 2 Diabetes
  • Coronary Artery Disease
  • Linagliptin
  • Placebo
  • Graz, Austria
    Medical University of Graz, Department for Internal Medicine
May 14, 2020

Healthy Trial in Biberach (Empagliflozin/linagliptin/metformin HCl, Empagliflozin, Linagliptin)

Completed
  • Healthy
  • Empagliflozin/linagliptin/metformin HCl
  • +3 more
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Feb 25, 2020

Healthy Trial in Biberach (Empagliflozin, Metformin HCl, Linagliptin (fixed dose combination), Empagliflozin, Linagliptin)

Completed
  • Healthy
  • Empagliflozin, Metformin HCl, Linagliptin (fixed dose combination)
  • +3 more
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Feb 6, 2020

Type 2 Diabetes Trial in Hellerup (LY2403021, LY2403021 , Standardised liquid meal)

Completed
  • Type 2 Diabetes
  • Hellerup, Denmark
    Center for Diabetes Research, Gentofte Hospital, Copenhagen Univ
Apr 6, 2020

Diabetes, Type 2 Trial in China (, linagliptin, background therapy)

Completed
  • Diabetes Mellitus, Type 2
  • placebo
  • +2 more
  • Beijing, China
  • +24 more
Mar 24, 2020

Replication of the CARMELINA Diabetes Trial in Healthcare Claims

Unknown status
  • Diabetes
  • Boston, Massachusetts
    Brigham & Women's Hospital
Jan 28, 2020

Type2 Diabetes, Albuminuria, Renal Insufficiency Trial in Seoul (Evogliptin, Linagliptin)

Completed
  • Type2 Diabetes Mellitus
  • +2 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 19, 2019

Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma Trial in Worldwide (5-Fluorouracil

Recruiting
  • Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
  • 5-Fluorouracil (5-FU)
  • +11 more
  • Scottsdale, Arizona
  • +41 more
Jan 19, 2023

Real World Glycemic Effectiveness of Linagliptin

Completed
  • Diabetes Mellitus, Type 2
  • Linagliptin
  • Eden Prairie, Minnesota
    Optum
Feb 1, 2019

Type 2 Diabetes Trial in United States (Linagliptin, Basal Bolus, Linagliptin + 50% Glargine dose on discharge)

Completed
  • Type 2 Diabetes
  • Linagliptin
  • +3 more
  • Denver, Colorado
  • +4 more
Feb 18, 2019

Type2 Diabetes Trial in Seoul (Teneligliptin, Linagliptin)

Completed
  • Type2 Diabetes Mellitus
  • Seoul, Korea, Republic of
    Asan Medical Center
Feb 20, 2019

Diabetes, Type 2 Trial in Japan (Linagliptin, Empagliflozin + linagliptin low dose, Empagliflozin + linagliptin low dose)

Completed
  • Diabetes Mellitus, Type 2
  • Linagliptin
  • +5 more
  • Aichi, Nagoya, Japan
  • +39 more
Sep 24, 2018

Schizophrenia Trial in Bandar Tun Razak (Linagliptin)

Terminated
  • Schizophrenia
  • Linagliptin
  • Bandar Tun Razak, Kuala Lumpur, Malaysia
    Pusat Perubatan Universiti Kebangsaan Malaysia
Aug 14, 2018

Diabetes Trial in Atlanta, Decatur (linagliptin, insulin glargine)

Completed
  • Diabetes
  • linagliptin
  • insulin glargine
  • Atlanta, Georgia
  • +3 more
Jul 25, 2018

New Onset Diabetes After Transplant, Kidney Transplant; Complications Trial in Shanghai (Empagliflozin, Linagliptin)

Unknown status
  • New Onset Diabetes After Transplant
  • Kidney Transplant; Complications
  • Shanghai, Shanghai, China
    Department of nephrology, endocrinology and kidney transplantati
Aug 20, 2018

Chronic Kidney Diseases, Type 2 Diabetes Trial in Seattle (Linagliptin, Glipizide)

Completed
  • Chronic Kidney Diseases
  • Type 2 Diabetes
  • Seattle, Washington
    University of Washington
Sep 12, 2018